约 1 个结果
在新选项卡中打开链接
Pemvidutide (ALT-801), a novel GLP-1/glucagon dual receptor agonist, achieves rapid and potent reductions in body weight and liver fat: Results of a placebo-controlled, double- blind, first- in-human (FIH)
跳至内容
Pemvidutide (ALT-801), a novel GLP-1/glucagon dual receptor agonist, achieves rapid and potent reductions in body weight and liver fat: Results of a placebo-controlled, double- blind, first- in-human (FIH)